Hibiscus Tea
Last reviewed October 2026 · Based on 17 studies
Bottom line
Hibiscus tea modestly lowers blood pressure, roughly 5-8 mmHg systolic and 3-4 mmHg diastolic across pooled trials, with bigger drops in people starting higher. It also slightly lowers fasting blood sugar, and is generally well tolerated, though longer-term safety data are limited.
What it helps with
- Lowers blood pressure — Benefit, evidence grade B (Moderate). Meta-analyses of randomised trials, newest with 26 trials and about 1,800 people; downgraded once because blood pressure is a surrogate marker.
- Lowers fasting blood sugar — Benefit, evidence grade C (Limited). Two small meta-analyses of trials found slightly lower fasting glucose; downgraded for small samples and surrogate marker.
What it is
Hibiscus tea is a tisane brewed from the calyces of Hibiscus sabdariffa, also called sour tea, roselle or red tea [1]. The plant is rich in organic acids, polyphenols, anthocyanins and polysaccharides [2]. Trials have tested it as brewed tea drunk 2-3 times a day, as capsules or powders of dried calyx, and as bottled roselle drinks [3][4][5].
How it might work
The proposed explanation is that its polyphenols and anthocyanins relax blood vessels and act as antioxidants, though this is not proven in humans [2][5]. A trial found a salt-excreting (natriuretic) effect in the hibiscus group, which would plausibly lower pressure [4]. A single-dose study found better flow-mediated vessel dilation after hibiscus extract, a short-term sign of vessel relaxation [6].
What the research says
A 2015 meta-analysis of 5 trials (390 people) found systolic pressure down 7.58 mmHg and diastolic down 3.53 mmHg, with larger effects from higher starting pressure [2]. A 2020 meta-analysis of 7 trials (362 people) found falls of 4.71 mmHg systolic and 4.08 mmHg diastolic, plus fasting glucose down 3.67 mg/dL [7]. A 2025 umbrella review of 26 trials (1,797 people) found dose-dependent blood-pressure falls against placebo and other teas, similar on average to drugs, with credible drops over 10 mmHg in people over 50, in trials over four weeks, and in low-bias trials; it also reported lower total and LDL cholesterol, lower fasting glucose, higher HDL, and a small cholesterol-picture improvement overall [8]. A separate 2020 meta-analysis found fasting glucose down 3.96 mg/dL and LDL down 7.84 mg/dL, with no clear change in total cholesterol, HDL or triglycerides [9]. Against drugs directly, hibiscus matched captopril over 8 weeks and hydrochlorothiazide over 4 weeks, while ramipril beat it on systolic pressure over 4 weeks [10][11][4]. A strict 2021 Cochrane review counted only one small placebo-controlled trial in hypertension and called the evidence insufficient, with very uncertain estimates [1].
Doses used in studies
Brewed-tea trials mostly used 2-3 servings a day for 4-6 weeks [3][12][13]. Capsule trials used dried calyx powder such as 320 mg twice a day for 4 weeks, or roselle extract totalling 5,600 mg a day for 8 weeks [4][1]. A bottled roselle drink trial ran 200 mL a day for 6 months [5]. A hibiscus-olive product was dosed twice a day for 8 weeks [10]. These are study doses, not recommendations.
Safety and interactions
Common side effects looked minor in trials: the 2025 review found no higher risk of adverse events with hibiscus, and a 4-week trial reported no side effects [8][11]. No established upper intake limit or toxic dose was reported in the reviews read [8]. Because hibiscus lowers blood pressure, combining it with blood-pressure or water-pill medicines could lower pressure too far, so people on these drugs should talk to a doctor first [8][4]. No blood-sugar-medicine interaction data were reported, though hibiscus slightly lowers fasting glucose [7][9]. No pregnancy or breastfeeding safety data appeared in the reviews read, so pregnant or breastfeeding people should be cautious and ask a doctor [8][14]. People with low blood pressure or kidney or liver disease have no dedicated safety data; one review noted a small, clinically unimportant rise in a liver enzyme (AST) with hibiscus [8].
Caveats and open questions
Most trials were small and lasted only weeks, and the strictest review judged the evidence insufficient on its narrow criteria [1][7]. Some products mixed hibiscus with olive leaf or lemon verbena, so the hibiscus-only share of the effect is unclear [10][15]. Blood pressure is a risk marker rather than a heart attack or stroke outcome, so the hoped-for heart benefit is inferred rather than shown [8].
References
- Roselle for hypertension in adults.. Cochrane Database Syst Rev, 2021.
- Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens, 2015.
- Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults.. J Nutr, 2010.
- Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa.. J Hum Hypertens, 2017.
- Improvement on blood pressure and skin using roselle drink: A clinical trial.. J Food Biochem, 2022.
- Acute Effects of Hibiscus Sabdariffa Calyces on Postprandial Blood Pressure, Vascular Function, Blood Lipids, Biomarkers of Insulin Resistance and Inflammation in Humans.. Nutrients, 2019.
- The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta-analysis of randomized clinical trials.. Phytother Res, 2020.
- Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis.. Complement Ther Med, 2025.
- The antidiabetic and antilipidemic effects of Hibiscus sabdariffa: A systematic review and meta-analysis of randomized clinical trials.. Food Res Int, 2020.
- Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts (NW Roselle): A phase-II, randomized, double-blind, captopril-controlled clinical trial.. Phytother Res, 2020.
- Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide.. Niger J Clin Pract, 2015.
- The effect of green tea and sour tea on blood pressure of patients with type 2 diabetes: a randomized clinical trial.. J Diet Suppl, 2013.
- The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes.. J Hum Hypertens, 2009.
- Safety classification of herbal medicine use among hypertensive patients: a systematic review and meta-analysis.. Front Pharmacol, 2024.
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of a Polyphenolic Extract (Hibiscus sabdariffa and Lippia citriodora) for Reducing Blood Pressure in Prehypertensive and Type 1 Hypertensive Subjects.. Molecules, 2021.